Infant formula counterfeits & terrorism
This article was originally published in The Tan Sheet
Executive Summary
FDA recently "became aware of infant formula that was tampered with that was used to fund al Quaeda operatives," FDA Associate Commissioner for Regulatory Affairs Steven Niedelman said at the Food & Drug Law Institute's Enforcement & Litigation Conference in Washington D.C. Sept. 23. "Terrorism has become a big issue for the agency and one that all firms need to take into account," he noted. House Energy & Commerce Committee Senior Counsel Alan Slobodin asserted two years ago that terrorist organizations often are financed through counterfeit trade of consumer products such as infant formula (1"The Tan Sheet" Oct. 8, 2001, In Brief)...
You may also be interested in...
FDA "National Security" Mission: Counterfeiting And Bioterrorism?
FDA should heighten its focus on product security to ensure counterfeiting does not take place, not only for consumer safety, but to cut off a source of income for terrorists, asserted House Energy & Commerce Committee Senior Counsel Alan Slobodin.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.